Investigating how bacteria communicate to develop new antibiotics
Chemical tools to investigate chain-flipping in quorum signal synthases
This study is looking at how certain bacteria communicate with each other to form protective layers and produce harmful substances, and it aims to find new ways to stop these bacteria from causing infections that are hard to treat.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boise State University NIH-funded |
| Lab location | 1 site (Boise, United States) |
| Project ID | NIH-11035229 on NIH RePORTER |
What this research studies
This research focuses on understanding how certain bacteria use chemical signals to coordinate their behavior, which includes forming biofilms and producing toxins. By studying the enzymes that create these signals, researchers aim to develop specific inhibitors that can block these processes, potentially leading to new treatments for multidrug-resistant bacterial infections. The approach involves detailed biochemical assays to explore the unique binding and reaction mechanisms of these enzymes, particularly how they interact with acyl carrier proteins. This could pave the way for innovative antimicrobial therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from multidrug-resistant bacterial infections.
Not a fit: Patients with infections caused by bacteria that are not affected by quorum sensing mechanisms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics that effectively combat resistant bacterial infections.
How similar studies have performed: While the approach of targeting quorum sensing in bacteria is gaining traction, this specific investigation into chain-flipping mechanisms is relatively novel and has not been extensively tested.
Where this research is happening
Boise, United States
- Boise State University — Boise, United States (Active)
Researchers
- Principal investigator: Nagarajan, Rajesh — Boise State University
- Study coordinator: Nagarajan, Rajesh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.